Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.

Follow


Submissions from 2024

File

3-21-2024          Acute Bleeding Catastrophe: A FACTOR to consider, Harkarandeep Singh, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health

Link

3-21-2024          Narrative medicine interventions for oncology clinicians: a systematic review, Trisha K. Paul, Department of Oncology, Division of Quality of Life and Palliative Care, St. Jude Children's Research Hospital, Memphis, TN, USA., Yashaswi Reddy, Kakatiya Medical College, Warangal, Telangana, India., Anthara Gnanakumar, George Washington University School of Medicine, Washington, DC, USA., et al.

File

2-29-2024          Women and Bleeding Disorders, Robin M. Reid, Rochester Regional Health

Link

2-9-2024          Breast cancer detection using enhanced IRI-numerical engine and inverse heat transfer modeling: model description and clinical validation, Carlos Gutierrez, Rochester Institute of Technology, Rochester, USA., Alyssa Owens, Rochester Institute of Technology, Rochester, USA., Lori Medeiros, Rochester Regional Health, et al.

Link

2-1-2024          Collaborative Care: A Model for Embedding Counseling in Oncology and Palliative Care, Earon Lehning, Rochester Regional Health

Link

2-1-2024          Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thrombotic thrombocytopenic purpura, Niraj Neupane, Rochester Regional Health, Sangharsha Thapa, Kathmandu University School of Medical Sciences Dhulikhel Nepal., Amir Mahmoud, Rochester Regional Health, et al.

Link

2-1-2024          Should primary care physicians consult on their admitted patients? A single-center survey study, Basil George Verghese, Rochester Regional Health, Mohamed Salah Mohamed, Rochester Regional Health, Anas Hashem, Rochester Regional Health, et al.

Link

1-1-2024          ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms, Hassan Awada, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Manasa Bhatta, Department of Medicine, The Mount Sinai Hospital, New York, NY, USA., Han Yu, Department of Biostatistics & Bioinformatic, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., et al.

Link

1-1-2024          Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia, Niraj Neupane, Rochester Regional Health, Soon K. Low, Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Himal Kharel, Rochester Regional Health, et al.

Submissions from 2023

Link

12-1-2023          Comparative Analysis of Palliative Care Needs Identified in Inpatient Rehabilitation and Skilled Nursing Facilities by Multidisciplinary Team Members, Erin Kelly; Elizabeth Spina, Rochester Regional Health; and John Liantonio

Link

12-2023          Spinal Plasmacytoma Transformed into Solitary Sacral Amyloidoma: A Case Report, Niraj Neupane, Rochester Regional Health, Himal Kharel, Rochester Regional Health, Mohammad Ammad Ud Din, Hematology/Oncology, H. Lee Moffitt Cancer and Research Institute, Tampa, Florida., et al.

Link

11-2-2023          Comparative Analysis of Hospital Outcomes for Thrombotic Thrombocytopenic Purpura between 2018 and 20120: A National Inpatient Sample Database Study, Niraj Neupane, Rochester Regional Health, Arnav Srivastava, Rochester Regional Health, Shubham Agrawal, et al.

Link

11-2-2023          Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients; A Scoping Review, Olga Lytvynova, Jenna Jwayyed, Maha Hameed, et al.

Link

11-2-2023          Transplacental Transfer of Emicizumab: Experience with Emicizumab in a Pregnant Female with Severe Hemophilia Α and an Inhibitor, Zeni Kharel, Rochester Regional Health, Rajiv K. Pruthi, Peter A. Kouides, Rochester Regional Health, et al.

Link

11-1-2023          Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities, Marshall A. Lichtman, James P. Wilmot Cancer Institute, University of Rochester Medical Center. and Ronald Sham, Rochester Regional Health

Link

11-2023          P2.17-07 Real-world Safety and Dosing of Lurbinectedin-Treated Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Preliminary Analysis, B. Halmos, Albert Einstein College of Medicine, Bronx, United States, P. Lammers, Baptist Cancer Center, Memphis, United States, Mehul Patel, Rochester Regional Health, et al.

Link

11-1-2023          Severe cutaneous necrosis in antiphospholipid syndrome, Mariam A.O. Mostafa, Rochester Regional Health, Amir Mahmoud, Rochester Regional Health, Hebat-Allah Egiza, Egypt-Japan University for Science and Technology, Alexandria, Egypt., et al.

File

10-19-2023          Homologous Recombination Deficiency, Genetics, PARP Inhibitors, and Screening in Cancer, Amy Bodrog, Rochester Regional Health

Link

10-1-2023          Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review, William J. Archibald, James P Wilmot Cancer Institute, Division of Hematology and Medical Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry., Peter A. Kouides, Rochester Regional Health, Majed A. Refaai, Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., et al.

Link

9-28-2023          Cancer survivorship challenges of rural older adults: a qualitative study, Evelyn Arana-Chicas, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA., Laura M. Prisco, Geriatric Oncology Research Group, University of Rochester Medical Center, Rochester, NY, USA., Saloni Sharma, Geriatric Oncology Research Group, University of Rochester Medical Center, Rochester, NY, USA., et al.

Link

9-2023          Hemophagocytic Lymphohistiocytosis and Pancreatic Cancer: A Rare Association, Ali Jaan, Rochester Regional Health, Farhan Khalid, Department of Internal Medicine, Monmouth Medical Center, Long Branch, NJ, USA., Abdullah M. Firoze Ahmed, Rochester Regional Health, et al.

Link

8-1-2023          Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study, Ali Abdelhay, Rochester Regional Health, Amir A. Mahmoud, Rochester Regional Health, Omar Al Ali, Rochester Regional Health, et al.

Link

7-20-2023          Therapy-related Acute Myeloid Leukemia in Non-Hodgkin Lymphoma Survivors: Risk, Survival Outcomes and Prognostic Factor Analysis, Utsav Joshi, Rochester Regional Health, Adheesh Bhattarai, Department of Internal Medicine, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal., Suman Gaire, Department of Internal Medicine, Mount Sinai Chicago, Chicago, IL, USA., et al.

Link

7-1-2023          Treatment delay and outcomes in elderly thrombotic thrombocytopenic purpura patients: A nationwide analysis, Amir A. Mahmoud, Rochester Regional Health, Ali Abdelhay, Rochester Regional Health, Mariam Mostafa, Rochester Regional Health, et al.

Link

6-1-2023          The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines, Sanjana Kalvehalli Kashinath, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health